challenges
The BSF industry operates at industrial scale but remains limited to low-margin commodity goods like protein meal and fertiliser.
solution
Entozyme's genetic toolkit unlocks the potential of BSF for enhanced waste processing and repurposes it to biomanufacture high-value therapeutics, nutraceutical oils and specialty biomaterials. Its first go-to-market is Omega-3 oil, where demand far exceeds supply from traditional aquaculture.
You might also like
For founders
Building for the systems that matter? Pitch us.
We back founders turning breakthrough science into category-defining companies.
For investors
Invest with Main Sequence
Access Australia's deep tech frontier alongside us.








